Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy-Reference-Cited by-同舟云学术

Genetic Variants Associated With Cancer Therapy–Induced Cardiomyopathy

Published:2019-07-02 Issue:1 Volume:140 Page:31-41
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Garcia-Pavia Pablo¹²³,Kim Yuri⁴⁵,Restrepo-Cordoba Maria Alejandra¹²,Lunde Ida G.⁴⁶,Wakimoto Hiroko⁴,Smith Amanda M.⁷,Toepfer Christopher N.⁴⁸,Getz Kelly⁷,Gorham Joshua⁴,Patel Parth⁴⁹,Ito Kaoru⁴,Willcox Jonathan A.⁴,Arany Zoltan⁷,Li Jian⁷,Owens Anjali T.⁷,Govind Risha¹⁰¹¹,Nuñez Beatriz¹²,Mazaika Erica¹⁰¹¹,Bayes-Genis Antoni²¹³,Walsh Roddy¹⁰¹¹,Finkelman Brian⁷,Lupon Josep²¹³,Whiffin Nicola¹⁰¹¹¹⁴,Serrano Isabel¹⁵,Midwinter William¹⁰¹¹,Wilk Alicja¹⁰¹¹,Bardaji Alfredo¹⁵,Ingold Nathan¹⁰¹¹,Buchan Rachel¹⁰¹¹,Tayal Upasana¹⁰¹¹,Pascual-Figal Domingo A.²¹⁶,de Marvao Antonio¹⁰¹¹¹⁴,Ahmad Mian¹⁰¹¹,Garcia-Pinilla Jose Manuel²¹⁷,Pantazis Antonis¹⁰¹¹,Dominguez Fernando¹²,John Baksi A.¹⁰¹¹,O’Regan Declan P.¹⁴,Rosen Stuart D.¹⁰¹¹,Prasad Sanjay K.¹⁰¹¹,Lara-Pezzi Enrique²¹⁰¹⁸,Provencio Mariano¹²,Lyon Alexander R.¹⁰¹¹,Alonso-Pulpon Luis¹²,Cook Stuart A.¹⁰¹⁴¹⁹,DePalma Steven R.⁴²⁰,Barton Paul J.R.¹⁰¹¹,Aplenc Richard⁷,Seidman Jonathan G.⁴,Ky Bonnie⁷,Ware James S.¹⁰¹¹¹⁴,Seidman Christine E.⁴¹⁴²⁰⁹

Affiliation:

1. Hospital Universitario Puerta de Hierro, Madrid, Spain (P.G.-P., M.A.R.-C., F.D., L.A.-P.).

2. Centro de Investigación Biomédica en Red Enfermedades in Cardiovascular Diseases (CIBERCV), Madrid, Spain (P.G.-P., M.A.R.-C., A.B.-G., J. Lupon, D.A.P.-F., J.M.G.-P., F.D., E.L.-P., L.A.-P.).

3. University Francisco de Vitoria, Pozuelo de Alarcón, Madrid, Spain (P.G.-P.).

4. Harvard Medical School, Boston, MA (Y.K., I.G.L., H.W., C.N.T., J.G., P.P., K.I., J.A.W., S.R.D., J.G.S., C.E.S.).

5. Massachusetts General Hospital, Boston (Y.K.).

6. Oslo University Hospital and University of Oslo, Norway (I.G.L.).

7. Perelman School of Medicine and University of Pennsylvania Health System, Philadelphia (A.M.S., K.G., Z.A., J. Li, A.T.O., B.F., R.A., B.K.).

8. University of Oxford (C.N.T.).

9. Brigham and Women's Hospital, Boston MA (P.P., C.E.S.).

10. National Heart & Lung Institute, Imperial College London, UK (R.G., E.M., R.W., N.W., W.M., A.W., N.I., R.B., U.T., A.d.M., M.A., A.P., A.J.B., S.D.R., S.K.P., E.L.-P., A.R.L., S.A.C., P.J.R.B., J.S.W.).

11. Royal Brompton & Harefield NHS Foundation Trust, London, UK (R.G., E.M., R.W., N.W., W.M., A.W., N.I., R.B., U.T., A.d.M., M.A., A.P., A.J.B., S.D.R., S.K.P., A.R.L., P.J.R.B., J.S.W.).

12. Hospital Universitario Puerta de Hierro, Universidad Autónoma de Madrid, Spain (B.N., M.P.).

13. Hospital Universitario Germans Trias i Pujol, Badalona, Spain (A.B.-G., J. Lupon).

14. MRC London Institute of Medical Sciences, Imperial College UK (N.W., D.P.O., S.A.C., J.S.W., C.E.S., A.d.M.).

15. Hospital Universitario de Tarragona Joan XXIII. IISPV, Rovira Virgili University, Spain (I.S., A.B.).

16. Hospital Universitario Virgen de la Arrixaca, University of Murcia. Spain (D.A.P.-F.).

17. Hospital Universitario Virgen de la Victoria, IBIMA, Malaga, Spain (J.M.G.-P.).

18. Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (E.L.-P.).

19. National Heart Centre Singapore and Duke-National University of Singapore (S.A.C.).

20. Howard Hughes Medical Institute, Chevy Chase, MD (S.R.D., C.E.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference49 articles.

1. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

2. Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

3. Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

4. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines

5. Cardiovascular Disease Among Survivors of Adult-Onset Cancer: A Community-Based Retrospective Cohort Study

Cited by 218 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Generation of four distinct isogenic cell lines with truncating variants in I-band or A-band titin;Stem Cell Research;2024-12

2. Cardiovascular Pharmacogenetics: From Discovery of Genetic Association to Clinical Adoption of Derived Test;Pharmacological Reviews;2024-08-09

3. Meta-analysis of genome-wide association studies for cancer therapy-related cardiovascular dysfunction and functional mapping highlight an intergenic region close to TP63;Scientific Reports;2024-08-08

4. Genetic factors in the pathogenesis of cardio-oncology;Journal of Translational Medicine;2024-08-05

5. Cardiovascular toxicity in antitumor therapy: biological and therapeutic insights;Trends in Cancer;2024-08